Topics covered: Traditional Chinese Medicine VS. Western Medicine In Chinese Pharma, Stem Cell-Based Technology, Small-Cap Specialty Pharma, Pending Health Care Reform, Patent Expiration, Indian Pharma VS. U.S. Pharma, FDA Approval Process, Expansion Into Asian Markets, Cultivating And Expanding R&D Pipelines, Competition From Generics, Clinical Research Outsourcing Market, Chinese Drug Manufacturers, Cancer Radiation Therapy, Brisk M&A Activity
Topics covered: Uptick In Internet Commerce, Social Networking To Drive Brand Awareness, Secular Shift In Market Share To Internet Retailers, Post-Crunch Consumer Confidence, Possible Consolidation Of HSN, Online Traffic Conversion Rates, Online Sales Holiday Outlook, Online Retailer Profit Margins Vs. Bricks-And-Mortar Retailers, Online Marketing Vs. In-Store Marketing, Maximized Markdowns, Inc., Growing Market Share For Online Travel Agents, E-Commerce As A Path To International Expansion, Amazon As The "Wal-Mart Of The Internet"
Topics covered: Trend Toward Orphan Disease Drug Development, Ownership Ego Preventing Shareholder Returns, IPO And Secondary Offering Window Opening, Impact Of Health Care Reform, Heightened M&A Activity, Generic Drug Competition, Gene Delivery Technology, Easier Credit For Small Cap Biotech Companies, Developments In Cancer Chemotherapeutics, Decreased Clinical Development Risk, Current Length Of FDA Approval Process, Convergence Of Large-Cap Biotech And Pharmaceutical Companies, Big Pharma R&D Pipeline
Topics covered: Valuations, Unit Volume, Undervalued Stocks, Technologies, Tax Rate, Sustainability and Predictability of Earnings Growth, Surge in Consumer Spending, Source of Earnings, Relative Opportunity &, Recovering Economy, Quality Control, Opportunity Cost, Innovation, Increasing Production, Increasing Dividend, Increase in Viewership, High Volatility, Growth, Growing Earnings, Foreign Income, Equity Research Capabilities, Effects of Healthcare Reform, Downside Protection, Domestic and Global Recovery, Divident Cuts, Discretionary Stocks, Development of New Products, Demand for Steel, Concentrated Portfolios, Coal Mining Operations, Canadian Banking, Bullish on Growth, Acquisitions
